GE HealthCare Technologies (NASDAQ:GEHC) Price Target Raised to $92.00

GE HealthCare Technologies (NASDAQ:GEHC) had its price target hoisted by Bank of America from $82.00 to $92.00 in a report issued on Monday,Benzinga reports. They currently have a neutral rating on the stock.

A number of other research analysts have also weighed in on GEHC. Morgan Stanley lifted their target price on GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a report on Thursday, October 30th. Citigroup raised their price target on GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a report on Thursday, December 11th. Jefferies Financial Group upped their price objective on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Evercore ISI increased their target price on GE HealthCare Technologies from $88.00 to $92.00 and gave the company an “outperform” rating in a research report on Thursday, October 30th. Finally, Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Seven research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $88.17.

GE HealthCare Technologies Trading Down 1.1%

Shares of GEHC opened at $85.76 on Monday. The firm has a market cap of $39.07 billion, a P/E ratio of 17.72, a price-to-earnings-growth ratio of 3.37 and a beta of 1.08. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. GE HealthCare Technologies has a 1 year low of $57.65 and a 1 year high of $94.80. The company has a 50 day simple moving average of $79.79 and a two-hundred day simple moving average of $76.47.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.02. The firm had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. GE HealthCare Technologies’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, equities analysts expect that GE HealthCare Technologies will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 2.89%.

Institutional Trading of GE HealthCare Technologies

A number of institutional investors have recently bought and sold shares of the stock. Glenview Trust co grew its stake in GE HealthCare Technologies by 4.4% in the 1st quarter. Glenview Trust co now owns 3,294 shares of the company’s stock worth $266,000 after acquiring an additional 139 shares in the last quarter. True North Advisors LLC boosted its holdings in shares of GE HealthCare Technologies by 2.0% in the third quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock valued at $525,000 after purchasing an additional 139 shares during the period. Klingman & Associates LLC grew its stake in GE HealthCare Technologies by 4.0% in the third quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock worth $273,000 after purchasing an additional 139 shares in the last quarter. Colonial Trust Advisors increased its holdings in GE HealthCare Technologies by 11.1% during the 3rd quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock worth $104,000 after purchasing an additional 139 shares during the period. Finally, Silver Oak Securities Incorporated raised its position in GE HealthCare Technologies by 4.6% during the 2nd quarter. Silver Oak Securities Incorporated now owns 3,183 shares of the company’s stock valued at $236,000 after purchasing an additional 140 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.